Differential regulation of the mitogen-activated protein and stress- activated protein kinase cascades by adrenergic agonists in quiescent and regenerating adult rat hepatocytes

Molecular and Cellular Biology

Volumn 17, Issue 7, 1997, Pages 3556-3565

  Spector, Mark S ^a   Auer, Kelly L ^a   Jarvis, W David ^a   Ishac, Edward J N ^a   Gao, Bin ^a   Kunos, George ^a   Dent, Paul ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; DNA SYNTHESIS INHIBITION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SPECIFICITY; FIBROBLAST; GENE REARRANGEMENT; GENE SWITCHING; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

ANIMALIA;

EID: 0030989153     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.7.3556     Document Type: Article

References (55)

1. Alessi, D. R., A. Cuenda, P. Cohen, D. Dudley, and A. Saltiel. 1995. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:12000-12008.
2. Beer, D. G., M. J. Neveu, D. L. Paul, U. R. Rapp, and H. C. Pilot. 1988. Expression of the c-Raf proto-oncogene, gamma-glutamyltranspeptidase, and gap junction protein in rat liver neoplasms. Cancer Res. 48:1610-1617.
3. Beltman, J., F. McCormick, and S. J. Cook, 1996. The selective protein kinase C inhibitor, RO-31-8220, inhibits mitogen activated protein kinase phosphatase-1 (MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase. J. Biol. Chem. 271:27018-27024.
4. Beyaert, R., A. Cuenda, W. Vanden Berghe, S. Plaisance, J. C. Lee, G. Haegeman, P. Cohen, and W. Fiers. 1996. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 15:1914-1923.
5. Bogoyevitch, M. A., J. Gillespie-Brown, A. J. Ketterman, S. J. Fuller, R. Ben-Levy, A. Ashworth, C. J. Marshall, and P. H. Sugden. 1996. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Circ. Res. 79:162-173.
6. Chapple, C. R. 1996. Selective alpha 1-adrenoreceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience. Eur. Urol. 29:129-144.
7. Chou, M. M., and J. Blenis. 1996. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1. Cell 85:573-583.
8. Crespo, P., T. G. Cachero, N. Xu, and J. S. Gutkind. 1995. Dual effect of beta-adrenergic receptors on mitogen-activated protein kinase. Evidence for a beta-gamma dependent activation and a G alpha s-cAMP-mediated inhibition. J. Biol. Chem. 270:25259-25265.
9. Cressman, D. E., L. E. Greenbaum, R. A. DeAngelis, G. Ciltberto, E. E. Furth, V. Poli, and R. Taub. 1996. Liver failure and defective hepatocyte regeneration in interleukin-6 deficient mice. Science 274:1379-1383.
10. Cuenda, A., J. Rouse, Y. N. Doza, R. Meier, P. Cohen, T. F. Gallagher, P. R. Young, and J. C. Lee. 1995. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:229-233.
11. Dent, P., W. Haser, T. A. J. Haystead, L. A. Vincent, T. M. Roberts, and T. W. Sturgill. 1992. Activation of mitogen-activated protein kinase by v-Raf in NIH 3T3 cells and in vitro. Science 257:1404-1407.
12. Dent, P., D. B. Reardon, D. K. Morrison, and T. W. Sturgill. 1995. Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-indcpendent mechanisms in vitro. Mol. Cell. Biol. 15:4125-4135.
13. Dent, P., M. Specter, B. Gao, E. Ishac, and G. Kunos. Unpublished data.
14. Desouets, C., G. Drouin, S. Matesic, N. Foulkes, C. Molina, P. Sassone-Corsi, C. Brechot, and P. Sobezak-Thepot. 1994. Cyclin A gene regulation by the cAMP transduction pathway. Hepatology 20:217A. (Abstract.)
15. Diehl, A. M., and R. M. Rai. 1996. Regulation of signal transduction during liver regeneration. FASEB J. 10:215-227.
16. Diehl, A. M., S. Q. Yang, M. Yin, H. Z. Lin, S. Nelson, and G. Bagby. 1995. Tumor necrosis factor-alpha modulates CCAAT/enhancer binding protein activities and promotes hepatocyte-specific gene expression during liver regeneration. Hepatology 22:252-261.
17. Diehl, A. M., S. Q. Yang, U. Wolfgang, and G. Wand. 1992. Differential expression of guanine nucleotide binding proteins enhances cAMP synthesis in regenerating liver. J. Clin. Invest. 89:1706-1712.
18. Fabian, J. R., I. Daar, and D. K. Morrison. 1993. Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. Mol. Cell. Biol. 13:7170-7179.
19. Fang, X. J., A. Keating, M. Flowers, C. C. Liew, H. Gupta, G. B. Mills, and M. Sherman. 1993. The v-Raf oncogene enhances tumorigenicity and suppresses differentiation in vivo in a rat hepatocyte cell line. Carcinogenesis 14:669-674.
20. Gines, P., X. Li, J. L. Zamarripa, S. E. Brown, E. D. Wieder, T. Nakamura, P. S. Guzelian, R. W. Schrier, L. E. Heasley, and R. A. Nemenoff. 1995. Tyrosine kinase growth factor receptors hut not seven-membrane spanning receptors or phorbol esters activate mitogen-activated protein kinase in rat hepatocytes. Hepatology 22:1296-1303.
21. Grant, S., A. J. Freemerman, M. J. Birrer, H. A. Martin, A. J. Turner, E. Szabo, J. Chelliah, and W. D. Jarvis. 1996. Effect of 1-b-D-arabinofurano-sylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant negative mutant protein (TAM67). Cell Growth Differ. 7:603-613.
22. Grant, S., and W. D. Jarvis. 1996. Modulation of drug-induced apoptosis by interruption of the protein kinase C signal transduction pathway: a new therapeutic strategy. Clin. Cancer Res. 2:1915-1920.
23. Grieco, D., A. Porcellini, E. V. Avvedimento, and M. E. Gottesman. 1996. Requirement for cAMP-PKA pathway activation by M phase promoting factor in the transition from mitosis to interphase. Science 271:1718-1723.
24. Hawes, B. E., T. van Biesen, W. J. Koch, L. M. Luttrell, and R. J. Lefkowitz. 1995. Distinct pathways of Gi-and Gq-mediated mitogen-activated protein kinase activation. J. Biol. Chem. 270:17148-17153.
25. Hu, Z.-W., X.-Y. Shi, R. Z. Lin, and B. B. Hoffman. 1996. Alpha 1 adrenergic receptors activate phosphatidylinositol 3-kinase in human vascular smooth muscle cells. Role in mitogenesis. J. Biol. Chem. 271:8977-8982.
26. Ishac, E. J. N., E. Lazar-Wesley, and G. Kunos. 1992. Rapid inverse changes in alpha 1B-and beta 2-adrenergic receptors and gene transcripts in acutely isolated rat liver cells. J. Cell. Physiol. 152:79-86.
27. Jelinek, T., P. Dent, T. Sturgill, and M. Weber. 1996. Ras-induced activation of Raf-1 is dependent on tyrosine phosphorylation. Mol. Cell. Biol. 16:1027-1034.
28. Kolch, W., G. Heidecker, P. Lloyd, and U. R. Rapp. 1991. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature 349:426-428.
29. 2adrenergic receptors. Ann. N.Y. Acad. Sci. 757:261-270.
30. Lin, T. A., T. A. J. Haystead, A. Pause, G. Belsham, N. Sonenberg, and J. C. Lawrence. 1994. PHAS-I as a link between mitogen activated protein kinase and translation initiation. Science 266:653-656.
31. Loyer, P., S. Cariou, D. Glaise, M. Bilodeau, G. Baffet, and C. Gugen-Guillouzo. 1996. Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. J. Biol. Chem. 271:11484-11492.
32. Marais, R., Y. Light, H. Paterson, and C. J. Marshall. 1995. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 14:101-110.
33. McConkey, D. J., M. Jondal, and S. Orrenius. 1992. Cellular signaling in thymocyte apoptosis. Semin. Immunol. 4:371-377.
34. McKenzie, F. R., and J. Pouyssegur. 1996. cAMP-mediated growth inhibition in fibrohlasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition. J. Biol. Chem. 271:18-26.
35. Mendelson, K. G., L. R. Contois, S. G. Tevosian, R. J. Davis, and K. E. Paulson. 1996. Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc. Natl. Acad. Sci. USA 93:12908-12913.
36. Michalopoulos, G. K. 1990. Liver regeneration: molecular mechanisms of growth control. FASEB J. 4:176-187.
37. Preiksaitis, H. G., W. H. Kan, and G. Kunos. 1982. Decreased α1-adrenoreceptor responsiveness and density in liver cells of thyrodectomized rats. J. Biol. Chem. 257:4321-4327.
38. Refsnes, M. R., G. H. Thoresen, G. Sandnes, O. F. Dajanai, L. Dajani, and T. Christoffersen. 1992. Long term inhibitory effect on beta adrenoreceptor acquisition and nonselective attenuation of adenylate cyclase in hepatocytes. J. Cell. Physiol. 151:164-171.
39. Reuter, C. W. M., A. D. Catling, T. Jelinek, and M. J. Weber. 1995. Biochemical analysis of MEK activation in NIH 3T3 fibroblasts: identification of B-Raf and other activators. J. Biol. Chem. 270:7644-7655.
40. Roesler, W. J., S. M. Crosson, C. Vinson, and P. J. McFie. 1996. The α-isoform of the CCAAT/enhancer-binding protein is required for mediating cAMP responsiveness of the phosphoenolpyruvate carboxykinase promoter in hepatoma cells. J. Biol. Chem. 271:8068-8074.
41. Rosette, C., and M. Karin. 1996. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor receptors. Science 274:1194-1197.
42. Sandnes, D., T. E. Sand, G. Sager, G. O. Bronstad, M. R. Refsnes, I. G. Gladhug, S. Jacobsen, and T. Christoffersen. 1986. Elevated level of beta-adrenergic receptors in hepatocytes from regenerating rat liver. Exp. Cell Res. 165:117-126.
43. Sevetson, B. R., X. Kong, and J. C. Lawrence. 1993. Increasing cAMP attenuates activation of mitogen activated protein kinase. Proc. Natl. Acad. Sci. USA 90:10305-10309.
44. Stanton, V. P., D. W. Nichols, A. P. Laudano, and G. M. Cooper. 1989. Transforming potential of a series of c-Raf-1 deletion mutants. Mol. Cell. Biol. 9:639-645.
45. Storm, S. M., J. L. Cleveland, and U. R. Rapp. 1990. Expression of Raf family proto-oncogenes in normal mouse tissues. Oncogene 5:345-351.
46. Tao, J.-S., J. S. Sanghera, S. L. Pelech, G. Wong, and J. G. Levy. 1996. Stimulation of stress activated protein kinase and p38 HOG1 kinase in murine keratinocytes following photodynamic therapy with benzoporphyrin derivative. J. Biol. Chem. 271:27107-27115.
47. Verheij, M., R. Bose, X. H. Lin, B. Yao, W. D. Jarvis, S. Grant, M. J. Birrer, E. Szabo, L. Zon, J. M. Kyriakis, A. Haimovitz-Friedman, Z. Fuks, and R. N. Kolesnik. 1996. Requirement for ceramide-initiated SAPK/JNK signaling in stress induced apoptosis. Nature 380:75-79.
48. Ware, J. L. 1993. Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev. 12:287-301.
49. Wu, J., P. Dent, T. Jelinek, A. Wolfman, M. J. Weber, and T. W. Sturgill. 1993. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′5′-monophosphate. Science 262:1065-1069.
50. Wu, J., P. Dent, and T. W. Sturgill. 1994. Regulation of MAP kinase signaling by insulin, p. 151-177. In B. Draznin and D. Le Roith (ed.), Molecular biology of diabetes II, vol. 2. Insulin action, effects on gene expression and regulation and glucose transport. Humana Press, Totowa, N.J.
51. Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
52. Xing, M., and P. A. Insel. 1996. Protein kinase C dependent activation of cytosolic phospholipase A2 and mitogen activated protein kinase by alpha1-adrenergic receptors in Madin-Darby canine kidney cells. J. Clin. Invest. 97:1302-1310.
53. Yao, B., Y. Zhang, S. Delikat, S. Mathias, S. Basu, and R. Kolesnik. 1995. Phosphorylation of Raf-1 by ceramide-activated protein kinase. Nature 378: 307-310.
54. Zhang, S., J. Han, M. A. Sells, J. Chernoff, U. G. Knaus, R. J. Ulevitch, and G. M. Bokoch. 1995. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J. Biol. Chem. 270: 23934-23936.
55. Zhang, Y.-Q., M. Kanzaki, H. Mashima, T. Mine, and I. Kojima. 1996. Norepinephrine reverses the effects of activin A on DNA synthesis and apoptosis in cultured rat hepatocytes. Hepatology 23:288-293.